Varma Mutual Pension Insurance Co Makes New $11.34 Million Investment in Agilent Technologies, Inc. $A

Key Points

• Varma Mutual Pension Insurance Co. initiated an approximately $11.34 million position in Agilent Technologies, purchasing 85,371 shares during the second quarter.
• Agilent reported quarterly EPS of $1.49, exceeding estimates by $0.08, while revenue rose 10% year over year to $1.83 billion. The company issued fiscal 2026 EPS guidance of $6.00–$6.10.
• Shares opened at $159.25, near their 52-week high, and analysts maintain a consensus “Moderate Buy” rating with a target price of $160.24.

Varma Mutual Pension Insurance Co bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 85,371 shares of the medical research company's stock, valued at approximately $11,340,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $26,000. SHP Wealth Management purchased a new position in Agilent Technologies in the 4th quarter valued at $26,000. Navalign LLC purchased a new position in Agilent Technologies in the 4th quarter valued at $27,000. Cedar Mountain Advisors LLC acquired a new stake in Agilent Technologies during the 1st quarter worth $27,000. Finally, MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies during the fourth quarter worth $28,000.

Agilent Technologies Stock Up 0.2%

Shares of A opened at $159.25 on Monday. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.51. The company has a market capitalization of $44.98 billion, a PE ratio of 31.98, a price-to-earnings-growth ratio of 2.80 and a beta of 1.25. The stock has a fifty day simple moving average of $137.57 and a two-hundred day simple moving average of $126.17. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the previous year, the firm earned $1.31 EPS. The company's quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. HSBC reduced their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They set a "hold" rating and a $135.00 price target on the stock. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective for the company. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, June 2nd. Finally, Bank of America raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and decreased their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source